Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,745 | -7,766 | -42,193 | -33,383 | -12,381 |
| Depreciation Amortization | 262 | 131 | 435 | 278 | 184 |
| Accounts receivable | -1,000 | N/A | N/A | -1,000 | N/A |
| Accounts payable and accrued liabilities | -2,684 | -2,213 | 2,654 | 824 | 698 |
| Other Working Capital | -2,309 | -3,364 | 10,517 | 6,427 | 1,152 |
| Other Operating Activity | 5,171 | 3,046 | 5,651 | 7,647 | -267 |
| Operating Cash Flow | $-16,305 | $-10,166 | $-22,936 | $-19,207 | $-10,614 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -21 | -530 | -573 | -459 |
| Investing Cash Flow | $-33 | $-21 | $-530 | $-573 | $-459 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 5,000 | 5,000 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 29,720 | 29,769 | 6,433 |
| Other Financing Activity | -696 | -557 | 0 | 0 | 0 |
| Financing Cash Flow | $4,304 | $4,443 | $34,720 | $29,769 | $6,433 |
| Beginning Cash Position | 19,986 | 19,986 | 8,732 | 8,732 | 8,732 |
| End Cash Position | 7,952 | 14,242 | 19,986 | 18,721 | 4,092 |
| Net Cash Flow | $-12,034 | $-5,744 | $11,254 | $9,989 | $-4,640 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,305 | -10,166 | -22,936 | -19,207 | -10,614 |
| Capital Expenditure | -33 | -21 | -530 | -573 | -459 |
| Free Cash Flow | -16,338 | -10,187 | -23,466 | -19,780 | -11,073 |